日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/07/20 | 962 | 985 | 962 | 980 | -6 | -0.6% | 155,000 |
| 2010/07/16 | 1,001 | 1,009 | 985 | 986 | -11 | -1.1% | 87,000 |
| 2010/07/15 | 1,009 | 1,009 | 995 | 997 | -11 | -1.1% | 96,000 |
| 2010/07/14 | 1,013 | 1,013 | 996 | 1,008 | +10 | +1% | 165,000 |
| 2010/07/13 | 1,023 | 1,026 | 995 | 998 | -11 | -1.1% | 206,000 |
| 2010/07/12 | 1,004 | 1,015 | 995 | 1,009 | +23 | +2.3% | 300,000 |
| 2010/07/09 | 1,023 | 1,028 | 982 | 986 | -56 | -5.4% | 683,000 |
| 2010/07/08 | 1,070 | 1,071 | 1,036 | 1,042 | -18 | -1.7% | 277,000 |
| 2010/07/07 | 1,033 | 1,065 | 1,030 | 1,060 | +26 | +2.5% | 373,000 |
| 2010/07/06 | 1,037 | 1,037 | 1,022 | 1,034 | -6 | -0.6% | 180,000 |
| 2010/07/05 | 1,038 | 1,047 | 1,025 | 1,040 | +3 | +0.3% | 194,000 |
| 2010/07/02 | 1,033 | 1,042 | 1,029 | 1,037 | +11 | +1.1% | 229,000 |
| 2010/07/01 | 1,030 | 1,035 | 1,022 | 1,026 | +16 | +1.6% | 393,000 |
| 2010/06/30 | 998 | 1,010 | 989 | 1,010 | +9 | +0.9% | 209,000 |
| 2010/06/29 | 996 | 1,013 | 993 | 1,001 | +5 | +0.5% | 157,000 |
| 2010/06/28 | 997 | 1,005 | 995 | 996 | +8 | +0.8% | 142,000 |
| 2010/06/25 | 964 | 988 | 964 | 988 | +25 | +2.6% | 249,000 |
| 2010/06/24 | 959 | 971 | 954 | 963 | -3 | -0.3% | 184,000 |
| 2010/06/23 | 976 | 976 | 962 | 966 | -10 | -1% | 235,000 |
| 2010/06/22 | 978 | 984 | 963 | 976 | -1 | -0.1% | 280,000 |
| 2010/06/21 | 996 | 996 | 975 | 977 | -16 | -1.6% | 204,000 |
| 2010/06/18 | 969 | 995 | 969 | 993 | +33 | +3.4% | 254,000 |
| 2010/06/17 | 965 | 965 | 952 | 960 | +3 | +0.3% | 152,000 |
| 2010/06/16 | 924 | 962 | 924 | 957 | +33 | +3.6% | 292,000 |
| 2010/06/15 | 941 | 942 | 916 | 924 | -26 | -2.7% | 281,000 |
| 2010/06/14 | 953 | 956 | 944 | 950 | -8 | -0.8% | 173,000 |
| 2010/06/11 | 957 | 962 | 951 | 958 | +14 | +1.5% | 123,000 |
| 2010/06/10 | 951 | 952 | 939 | 944 | -7 | -0.7% | 98,000 |
| 2010/06/09 | 948 | 956 | 944 | 951 | -6 | -0.6% | 108,000 |
| 2010/06/08 | 951 | 963 | 943 | 957 | +6 | +0.6% | 93,000 |
| 2010/06/07 | 950 | 957 | 948 | 951 | -19 | -2% | 79,000 |
| 2010/06/04 | 976 | 979 | 961 | 970 | -5 | -0.5% | 164,000 |
| 2010/06/03 | 980 | 983 | 973 | 975 | +4 | +0.4% | 114,000 |
| 2010/06/02 | 975 | 986 | 966 | 971 | -18 | -1.8% | 196,000 |
| 2010/06/01 | 1,000 | 1,000 | 987 | 989 | +3 | +0.3% | 105,000 |
| 2010/05/31 | 972 | 995 | 972 | 986 | +18 | +1.9% | 91,000 |
| 2010/05/28 | 963 | 975 | 963 | 968 | +13 | +1.4% | 143,000 |
| 2010/05/27 | 965 | 966 | 950 | 955 | -11 | -1.1% | 224,000 |
| 2010/05/26 | 982 | 982 | 965 | 966 | -6 | -0.6% | 217,000 |
| 2010/05/25 | 983 | 987 | 967 | 972 | -10 | -1% | 192,000 |
| 2010/05/24 | 981 | 999 | 980 | 982 | +10 | +1% | 234,000 |
| 2010/05/21 | 982 | 994 | 971 | 972 | -38 | -3.8% | 369,000 |
| 2010/05/20 | 1,010 | 1,027 | 1,008 | 1,010 | +4 | +0.4% | 198,000 |
| 2010/05/19 | 1,017 | 1,018 | 998 | 1,006 | -5 | -0.5% | 297,000 |
| 2010/05/18 | 1,012 | 1,029 | 1,003 | 1,011 | +14 | +1.4% | 402,000 |
| 2010/05/17 | 992 | 1,020 | 962 | 997 | -55 | -5.2% | 760,000 |
| 2010/05/14 | 1,057 | 1,066 | 1,048 | 1,052 | +7 | +0.7% | 343,000 |
| 2010/05/13 | 1,062 | 1,064 | 1,038 | 1,045 | +3 | +0.3% | 247,000 |
| 2010/05/12 | 1,057 | 1,060 | 1,037 | 1,042 | -15 | -1.4% | 225,000 |
| 2010/05/11 | 1,047 | 1,067 | 1,047 | 1,057 | -3 | -0.3% | 374,000 |
3601～
3650
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 329,100円 | +7.9% | +8.9% | 3.77% | 7.04倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 396,300円 | +20.9% | +87.3% | 3.43% | 8.85倍 | 1.02倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 180,900円 | +4.0% | +25.4% | 2.93% | 7.91倍 | 1.04倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 168,100円 | +5.0% | +1.5% | 0.00% | 14.43倍 | 3.84倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 53,600円 | +21.1% | - | 0.00% | 13.31倍 | 1.86倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム
